A detailed history of Louisbourg Investments Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Louisbourg Investments Inc. holds 42,249 shares of ABT stock, worth $5.44 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
42,249
Previous 45,549 7.24%
Holding current value
$5.44 Million
Previous $4.16 Billion 11.36%
% of portfolio
0.97%
Previous 1.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$111.93 - $119.39 $369,369 - $393,987
-3,300 Reduced 7.24%
42,249 $3.69 Billion
Q3 2024

Jan 29, 2025

SELL
$100.07 - $118.13 $330,231 - $389,829
-3,300 Reduced 6.76%
45,549 $4.16 Billion
Q2 2024

Jan 29, 2025

BUY
$100.73 - $112.44 $418,029 - $466,626
4,150 Added 9.28%
48,849 $4.01 Billion
Q1 2024

Jan 29, 2025

BUY
$109.52 - $120.96 $794,348 - $877,322
7,253 Added 19.37%
44,699 $4.06 Billion
Q4 2023

Jan 29, 2025

BUY
$90.19 - $110.4 $3.38 Million - $4.13 Million
37,446 New
37,446 $3.4 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Louisbourg Investments Inc. Portfolio

Follow Louisbourg Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisbourg Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Louisbourg Investments Inc. with notifications on news.